LONDON and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced financial and operational ...

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 vector technology.

MicroAlgo Inc. Develops Blockchain-Based Traceable IP Rights Protection Algorithm Shenzhen, May. 13, 2025/––MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), today announced the ...

NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...

Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing, announces the formation of its ...

A Forrester VP explains to TechRepublic readers why three of the top 10 emerging technologies for the year should be on ...

Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

Charles Dickens may not have had generative AI in mind when he wrote “It was the best of times, it was the worst of times…” ...

Q1 2025 - Earnings Conference Call May 12, 2025 8:00 AM ETCompany ParticipantsLucio Aldworth - Head-IRJohann Bordais ...

Explore the hidden trade-offs of AI-powered coding tools and learn strategies to maintain innovation and framework diversity.

The Disease Vector Education Center in St. Augustine, Florida, teaches kids about mosquitoes and disease prevention through ...